Predicted cardiac and second cancer risks for patients undergoing VMAT for mediastinal Hodgkin lymphoma
<p><strong>Background and purpose:</strong> To predict treatment-related cardiovascular disease (CVD) and second cancer 30-year absolute mortality risks (AMR<sub>30</sub>) for patients with mediastinal Hodgkin lymphoma in a large multicentre radiation oncology...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Springer
2022
|